Women's responsiveness to the second-line breast cancer drug fulvestrant may depend on whether the cancer cells are expressing two key proteins, scientists report.
Read »Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Health
- S-LOCUS EARLY FLOWERING 3 Is Exclusively Present in the Genomes of Short-Styled Buckwheat Plants that Exhibit Heteromorphic Self
- Best Way To Get Rid Of Acne Scars
- Unusual alliances enable movement
- Baby knows best: Baby-led weaning promotes healthy food preferences
- Eradication of Metastatic Renal Cell Carcinoma after Adenovirus-Encoded TNF-Related Apoptosis-Inducing Ligand (TRAIL)/CpG Immuno